CHRONIC HEPATITIS-C RESPONSE TO INTERFERON THERAPY - COMPARISON OF ALT NORMALIZATION WITH ANTI-HCV IGM, ANTI-HCV IGG, AND HCV-RNA POLYMERASE CHAIN-REACTION

被引：0
|
作者：
DOUGLAS, DD
RAKELA, J
LIN, HJ
TASWELL, HF
CZAJA, AJ
RABE, D
HOLLINGER, FB
机构：
[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[2] BAYLOR COLL MED,HOUSTON,TX 77030
来源：
HEPATOLOGY | 1991年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：A74 / A74
页数：1
相关论文
共 50 条
  • [31] Anti-HCV IgG avidity index in acute hepatitis C
    Coppola, N.
    Pisapia, R.
    Martini, S.
    Marrocco, C.
    Vatiero, L.
    Messina, V.
    Tonziello, G.
    Sagnelli, C.
    Filippini, P.
    Piccinino, F.
    Sagnelli, E.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S107 - S108
  • [32] Anti-HCV IgG avidity index in acute hepatitis C
    Coppola, Nicola
    Pisapia, Raffaella
    Marrocco, Cecilia
    Martini, Salvatore
    Vatiero, Luisa Maria
    Messina, Vincenzo
    Tonziello, Gilda
    Sagnelli, Caterina
    Filippini, Pietro
    Piccinino, Felice
    Sagnelli, Evangelista
    JOURNAL OF CLINICAL VIROLOGY, 2007, 40 (02) : 110 - 115
  • [33] Clinical importance of assessment of anti-HCV IGM antibodies in chronic hepatitis C
    Stransky, J
    Honzakova, E
    Vandasova, J
    Horejsova, M
    Kyncl, J
    Nemecek, V
    Horak, J
    ACTA VIROLOGICA, 1996, 40 (02) : 61 - 65
  • [34] HCV genotype is more useful than serum HCV RNA titre and IgM anti-HCV as predictor of sustained response to alpha IFN in chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Asti, L
    Silini, E
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : T6 - T6
  • [35] RISK OF HEPATITIS-C VIRUS (HCV) INFECTION IN RECIPIENTS OF BLOOD SCREENED FOR ANTI-HCV
    NELSON, K
    DONAHUE, J
    MUNOZ, A
    BROWN, D
    NESS, P
    REITZ, B
    YAWN, D
    MCALLISTER, H
    TRANSFUSION, 1992, 32 (08) : S49 - S49
  • [36] HEPATITIS-C VIRUS (HCV), ANTI-HCV AND NON-A, NON-B HEPATITIS
    GROB, PJ
    JOLLERJEMELKA, HJ
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 120 (05) : 117 - 124
  • [37] Impact of Anti-HCV Therapy and HCV-RNA Titer on Graft Survival after Liver Transplant in Patients with HCV
    Maki, A.
    Nishida, S.
    Tekin, A.
    Selvaggi, G.
    Levi, D.
    Fujii, H.
    Tzakis, A. G.
    TRANSPLANTATION, 2012, 94 (10) : 109 - 109
  • [38] HEPATITIS-C VIRUS (HCV) GENOTYPES AND CLINICAL COURSE OF ANTI-HCV POSITIVE CIRRHOSIS
    BENVEGNU, L
    PONTISSO, P
    CAVALLETTO, D
    CHEMELLO, L
    ALBERTI, A
    HEPATOLOGY, 1995, 22 (04) : 945 - 945
  • [39] PREVALENCE OF HEPATITIS-C ANTIBODY (ANTI-HCV) IN ALASKA NATIVES
    MCMAHON, BJ
    PARKINSON, AJ
    WAINWRIGHT, RB
    ZANIS, CL
    HEPATOLOGY, 1991, 14 (04) : A214 - A214
  • [40] Significant of anti-HCV core IgM in patients with chronic hepatitis C treated with interferon alfa.
    Pawlotsky, JM
    RoudotThoraval, F
    Pellerin, M
    Bastie, A
    Vitrat, D
    Duval, J
    Dhumeaux, D
    HEPATOLOGY, 1996, 24 (04) : 1057 - 1057
12345